. The LSK population also includes lymphoid-primed multipotent progenitors (LMPPs) whose potential is skewed toward lymphocyte and myeloid differentiation (2) . LMPPs are defined by a characteristically high cell surface concentration of Flt3 and express of a number of lymphoid transcripts, a process termed lymphoid priming. One of the genes subject to lineage priming is Rag1. Indeed the expression of a GFP reporter expressed from the Rag1 locus can be used to identify a population termed the early lymphoid progenitor (ELP) that overlaps with the LMPP (3). The common lymphoid progenitor (CLP) is developmentally downstream of the LMPP and its potential appears largely restricted to the lymphoid lineages, in vivo, if not in vitro (4) (5) (6) . CLPs upregulate expression of IL-7Rα, while maintaining Flt3 and Rag1/GFP (7, 8) . Signaling through both, Flt3 and IL-7Rα, is required for development to the B cell progenitor stages (9) . CLPs can be further divided through the expression of Ly6D into a true "all lymphocyte progenitor" (ALP, Ly6D − ), which can give rise to all lymphocytic lineages, and a "B cell biased lymphocyte progenitor" (BLP, Ly6D + ) (5, 7) . BLPs differentiate directly into committed B cells through the concerted activity of E2A, EBF1, and Pax5 (10) .
MaTerials anD MeThODs

Mice
The Spi1 gfp (floxed exon 5 of Spi1 and a GFP knockin into the 3′ untranslated region) (16) 
MxCre
+ mice were injected intraperitoneal (i.p.) with 5 µg/g body weight of polyIC (GE Healthcare) twice at 3-day intervals. Mice were analyzed 14, 28, and 42 days after the first polyIC injection. Experimental mice were used at 6-12 weeks of age and maintained on a C57Bl/6 background.
Preparation of hematopoietic Progenitors
Hematopoietic cells were flushed from the tibia and femur of both legs. To enrich for hematopoietic progenitor populations in the BM, antibodies to the following surface molecules were used immunomagnetic bead depletion of lineage (Lin) marker-positive BM cells: CD2 (RM2-1), CD3 (KT-3.1), CD8 (53-6.7), CD11b/ MAC-1 (M1-70), Gr-1 (RA6-8C5), B220 (RA3-6B2), and erythrocyte (TER119). Lin + cells were exposed to BioMag goat anti-rat IgG beads (Qiagen) and depleted with a Dynal MPC-L magnet (Invitrogen). Lin − BM cells were stained with labeled antibodies as described below.
Flow cytometry
The following anti-mouse mAbs were used: Sca-1 (E13161.7, produced in house), c-Kit (ACK2, produced in house), Flt3 (A2F10.1; BD Pharmingen), IL-7Rα (B12-1; eBioscience, Bioof), Ly6C (5075-3.6), Ly6D (49-H4, BD Pharmingen), CD19 (ID3; BD Pharmingen, eBioscience), B220 (RA3-6B2; BD Pharmingen, eBioscience), IgM (331.12, BD Pharmingen), NK1.1 (PK136, BD Pharmingen), CD49b (HMα2, BD Pharmingen), TCRβ (H57-597, BD Pharmingen), CD45.1 (A20, eBioscience), and CD34 (RAM34; BD Pharmingen). Anti-rat immunoglobulinphycoerythrin and PECy7-streptavidin (BD Pharmingen) were used as secondary detection reagents.
Single cell suspensions were prepared in balanced salt solution with 2% (v/v) fetal calf serum. Cell staining was on ice for 30 min with fluorescent or biotin conjugated antibodies and the samples were processed on an LSRII or LSRFortessa flow cytometer (BD Biosciences). Propidium iodide exclusion was used to determine cell viability. Data were analyzed using FlowJo software (Treestar Inc.).
rna isolation, amplification From lsK cells, and array analysis
Total RNA was isolated from LSK cells of PU.1 conditional deleted and wild-type animals (three pools of 15-20 mice treated with 5 µg/g of body weight polyIC 14 days previously) using RNeasy kits (Qiagen). RNA was amplified with the Illumina Total Prep RNA Amplification Kit (Ambion) and quantity and quality assessed using the Agilent Bioanalyzer 2100. Labeled cRNA was hybridized to Illumina MouseWG-6 V 2.0 Expression BeadChips at the Australian Genome Research Facility, Melbourne.
The resulting arrays were analyzed in R using the Bioconductor package limma (39) . Raw intensities were normalized by using the neqc function, which performs background and quantile normalization using control probes (40) . Probes not detected in any sample were removed (detection p value < 0.05). Pairwise comparisons used linear modeling and empirical Bayes moderated t statistics (41) . The false discovery rate (FDR) was controlled by the Benjamini-Hochberg algorithm. Differentially expressed probes had an FDR of <0.05. Multi-dimensional scaling (MDS) plot was produced using expression data for wild-type progenitor and stem cell populations obtained from http://haemosphere.org (42) using plotMDS function in limma using the top 500 differentially expressed genes. Lineage-specific gene sets obtained from http://haemosphere.org (42) were used in gene set tests. p Values were obtained with rotation gene set testing (ROAST) using the mroast in limma, Benjamini-Hochberg correction for multiple testing and 9,999 rotations. Barcode plots were made using the barcodeplot function of the limma package.
Gene ontology analyses were obtained from PANTHER Classification System version 11.0 (43) . Statistical overrepresentation test was performed on activated and repressed genes, using 
Quantitative real-Time rT-Pcr
Total RNA was isolated from purified cells using TRIzol (Invitrogen). cDNA synthesis used iScript Reverse Transcription Supermix (Bio-Rad). Quantification of gene expression was performed in triplicate with QuantiTect SYBR Green PCR kit (Qiagen) on a C1000 Thermal Cycler (Bio-Rad). The primers are listed in Table S1 in Supplementary Material.
In Vitro clonogenic assays
To determine the progenitor frequencies, sorted populations were seeded in limiting dilution on OP9 stromal cells in media containing 2% IL-7 supernatant and 5 ng/ml Flt3L. 350 nM 4-hydroxytamoxifen (4OT) was added at day 0. The media was diluted 1:3 on day 1 to reduce any cytotoxic effect of the 4OT. Cells were scored after 7-10 days as described (44) . The clonogenic frequency was calculated using the ELDA software (45) .
statistical analysis
Statistical analysis used the GraphPad Prism software. For the non-microarray data, sample size analysis indicates that the power to detect a twofold change with a type error of <5% and power of 90% confidence and an SD of 20% of the mean is 4 mice/ genotype. We used between 5 and 14 mice/genotype over two to three independent experiments as outlined in the figure legends. (12) , the defining marker of CLPs. To assess the impact of PU.1 inactivation for lymphoid progenitors independently of Flt3 and IL-7R, we have utilized an alternative strategy to identify these populations using Rag1/GFP (36) . Rag1/GFP expressing cells within the LSK population define ELPs (3-6% within the LSK cells), which has been demonstrated to be the true lymphoidprimed subset of the LMPP (3). Despite being lymphoid-primed, virtually all ELPs co-express CD34 and Flt3 ( Figure S3A in Supplementary Material) and only a low proportion (7.3 ± 1.2%) expressed cell surface IL-7R. Similarly, there is a high degree of surface marker expression overlap between conventionally 
Rag1
gfp/+ mice were injected with polyIC on days 0 and 3, and analyzed by flow cytometry on days 28 and 42. Total numbers of (a) LSK cells, (B) Rag1/GFP + early lymphoid progenitors, and (c) Rag1/ GFP + common lymphoid progenitors (CLPs) in the BM of indicated genotypes were calculated. The data are mean ± SD from between 5 and 8 mice per genotype. p Values compare the indicated groups using an unpaired t-test. *p < 0.05, **p < 0.01, ***p < 0.001. Figures 1C,D (35) ]. This analysis also revealed a highly significant reduction in the proportion of LSK cells without PU.1 (Figures 1D,E) . However, when absolute cellularity was determined, it became apparent that loss of PU.1 resulted in a twofold reduction in LSK cells (Figure 1F) . Thus the loss of PU.1 had a relatively mild impact on the frequency of LSK cells.
Analysis of the ELP fraction of the LSK revealed that PU.1 inactivation resulted in a significant decrease in the proportion and frequency of ELPs (Figures 2A-C) . Importantly, the remaining ELPs lacked Flt3, suggesting that they were PU.1 deficient (Figure 2A) . By contrast, analysis of the Rag1/GFP + CLP fraction showed an absence of CLPs in the BM, indicating that PU.1 was essential for the formation of these cells (Figures 2D-F) . Although the experiments described in Figures 1 and 2 were conducted 14 days after the initial polyIC treatment, we believe that this represented the steady-state situation as analysis of the frequency of the LSK, ELP, and CLP populations at days 28 and 42 after polyIC exposure produced very similar results (Figures 3A-C) . Taken together these data indicate that the requirement for PU.1 progressively increases as lymphoid progenitors transition between the LSK and CLP compartments.
PU.1 is Dispensable From the clP stage of Development
The data described above demonstrated that PU.1 was required for the development of Rag1/GFP + CLPs from LMPPs, although whether PU.1 has an essential function in CLPs was unclear. A previous study showed that removal of PU.1 in CLPs was compatible with B cell development (32) , however, as that study required the CLPs to be cultured for 2 days in B cell promoting conditions prior to Cre activation and PU.1 removal, it remained to be determined if PU. CreER T2 mice showed marked reduction in B cell clonogenic potential (11.9-fold reduction for HSCs and 14.7-fold reduction for LMPPs) compared to controls. By contrast, CLPs from the same mice were much less sensitive to PU.1 loss (threefold reduction compared to controls) a finding in agreement with a previous study (32) . Collectively, these results demonstrate that PU.1 is required for the LMPP to CLP transition and suggested no obligate role for this factor at subsequent points in early B cell development.
PU.1 activates lymphoid associated genes in MPP cells
In order to examine the transcriptional roles of PU.1 in early progenitor populations, we purified wild type (Spi1 Figure 5A ). Ebf1, another target of PU.1 in pro-B cells (52), was not differentially expressed between the wild type and PU.1-deficient hematopoietic progenitors. We confirmed the efficient inactivation of Spi1 as the signal detected from the oligonucleotide probe corresponding to the floxed Spi1 exon 5 decreased >80% in each sample ( Figure 5A ). Pathway analysis revealed that the activated genes encoded proteins mostly involved in signaling, adhesion, and metabolic processes, while the repressed genes were associated with developmental and immune processes ( Figure 5B) .
To explore the relationships between the wild type and PU.1-deficient hematopoietic progenitors in an unbiased way, we measured the transcriptional distance between any pair of expression profiles. This analysis used the leading fold change, defined as the average fold change for the 500 genes most different between the samples. Data are shown on an MDS plot where the distances on the plot correspond to log2-leading fold change ( Figure 5C ). This analysis revealed that PU.1-deficient LSK cells clustered closely to the myeloid progenitors (common myeloid progenitor and granulocyte macrophage progenitor), in contrast to the control LSK cells that clustered adjacent to the defined HSC (LT-and ST-) and MPP populations ( Figure 5C ). This conclusion was further supported by cell lineage-specific gene set testing showing that repressed genes were enriched for the neutrophil lineage associated transcripts (Figures 5A,D) , most likely representing the aberrant c-Kit int population observed in the PU.1-deficient LSK cells [ Figures 1C,D and (35) ]. Most importantly, signatures of MPPs, B cell, and DC lineages were lost in the absence of PU.1 ( Figure 5D) .
To confirm the role for PU.1 in promoting the transcriptional priming of lymphoid genes in the MPPs, we analyzed the expression of some of the cohort of neutrophil and B cell specific genes identified in Figure 5D , in purified Rag1/GFP + (ELP) and Rag1/ GFP − ("HSC") LSK cells, as well as Lin surface ( Figure S5 in Supplementary Material), and again by the reduced mRNA for Csf1r (encoded for MCSF-R) whose expression is regulated by PU.1 (53) (Figure 5E ). In agreement with the gene expression studies, we confirmed eight downregulated genes for the B cell lineage (Dntt, Cd79a, Oct2, Pcp4l1, Pf4, Tek, Slc22a18, and Aqp1) and two upregulated genes (Slpi, Nmes1) for neutrophil lineage in PU.1-deficient ELPs ( Figure 5E ). Together, these data demonstrate that PU.1 is broadly required to prime the expression of lymphoid genes and suppress some neutrophil genes in ELPs for subsequent formation into CLPs.
DiscUssiOn
PU.1 is one of a small group of transcriptional regulators, including Ikaros, E2A, Mef2c, EBF1, Myb, and Pax5 that control the specification and commitment of lymphoid progenitors to the B cell pathway (54) (55) (56) . Although, it has long been known that PU.1 is required for lymphocyte formation from either the fetal or adult HSCs, the function of PU.1 in lymphopoiesis and the exact point at which it is required has proven more elusive. Here, we demonstrate using conditional mutagenesis that PU.1 is required for efficient LMPP formation and for the subsequent differentiation to the CLP stage. It has been proposed that the concentration of PU.1 in MPPs determines myeloid (high PU.1) or lymphoid (low PU.1) outcomes (13) . Our analysis of Spi1 transcription using a GFP reporter allele that did not impact on PU.1 function (16) suggests that Spi1 was relatively uniformly expressed throughout early hematopoietic development, with expression peaking at the LMPP stage. These data mirrored closely the expression of Spi1 mRNA in wild-type hematopoietic cells. Within the lymphoid developmental pathway PU.1 expression slowly declined but was not markedly downregulated until the pro-B cell (Fraction B) stage. By contrast, myeloid progenitors cells express an even higher concentration of PU.1 than that observed in LMPPs, which peaks in mature myeloid cells (13, 15-17, 19, 30, 57) .
One of the limitations in mapping PU.1 function in early lymphopoiesis has been due to its role in the transcriptional regulation of the genes encoding Flt3 (30) . This analysis revealed that PU.1 was required for the efficient production of LMPPs and was essential for CLP formation. The requirement was very stage specific as the removal of PU.1 using Rag1/Cre was compatible with CLP formation and B cell differentiation, in agreement with a previous study using a less direct approach (32) . Thus, the critical role of PU.1 in lymphopoiesis occurs before the CLP stage of development by inducing lymphoid-specific genes and keeping myeloid genes in check at the LMPP stage. Although in the current study we have only addressed PU.1 function in adult BM lymphopoiesis, recent analysis of mice homozygous for a hypomorphic allele of Spi1 [UREΔ/Δ (20) ] demonstrated a concentration dependent function for PU.1 in controlling distinct waves of fetal and adult B-lymphopoiesis, suggesting additional complexities in the process (58) . It should also be noted that the importance of PU.1 in some aspects of later B cell differentiation, such as at the pre-and mature B cell stages is masked by functional redundancy with the closely related gene, SpiB (59) (60) (61) .
The phenotype arising from PU.1 deficiency, is broadly similar to that observed in mice lacking E2A (26), Mef2c (28), Ikaros (31, 62) , and Myb (27) , factors also required for the priming of lymphoid lineage genes in LSK cells. The links between PU.1 and the other members of this gene regulatory network are only partially understood. PU.1 directly regulates Mef2c, a factor that also regulates the myeloid versus lymphoid fate decision in hematopoietic progenitors and is essential for the formation of CLPs (28) . It has been proposed that PU.1 concentration is determined by a regulatory circuit whereby activation of the lymphocyte-promoting factor Ikaros, itself an essential for lymphopoiesis, represses PU.1 expression either directly or via the induction of the repressor Gfi1 (25) . In keeping with this concept, B cell development is impaired in the absence of Gfi1 and can be partially restored by the removal of one allele of Spi1 or by shRNA-mediated knockdown of Spi1. Interestingly, Gfi1 expression was increased in PU.1-deficient LSK cells, suggesting that PU.1 also functions at some level to repress Gfi1 ( Figure 5A ). Similar counteracting networks are also known to result in multi-lineage priming and contribute to myeloid cell Defining PU. lineage determination (63) . Together with the regulation of the two key cytokine receptors, Flt3 and IL-7R, it is likely that the regulation of these targets is sufficient to explain the important function of PU.1 in the transition from the LMPP to CLP stage of development.
aVailaBiliTY OF DaTa anD MaTerial
The microarray gene expression data are publicly available at the Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo), accession number GSE89642.
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